title: Taking dendritic cells into medicine.
abstract: Dendritic cells (DCs) orchestrate a repertoire of immune responses that bring about resistance to infection and silencing or tolerance to self. In the settings of infection and cancer, microbes and tumours can exploit DCs to evade immunity, but DCs also can generate resistance, a capacity that is readily enhanced with DC-targeted vaccines. During allergy, autoimmunity and transplant rejection, DCs instigate unwanted responses that cause disease, but, again, DCs can be harnessed to silence these conditions with novel therapies. Here we present some medical implications of DC biology that account for illness and provide opportunities for prevention and therapy.
authors: The Rockefeller University, New York 10065, USA. steinma@mail.rockefeller.edu
authors: Ralph M
authors: RM
authors: Steinman
authors: Jacques
authors: J
authors: Banchereau
mesh_terms: D003141:Communicable Diseases / Q000276:immunology / Q000628:therapy; D003713:Dendritic Cells / Q000166:cytology / Q000276:immunology*; D006801:Humans; D007154:Immune System Diseases / Q000276:immunology / Q000503:physiopathology / Q000628:therapy; D008511:Medicine / Q000379:methods; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D014181:Transplantation Immunology